LFWD Lifeward Accounting Capitalization

Corporate emblem and logo of rewalk.com (LFWD)

This daily price chart for ReWalk Robotics Ltd. (LFWD) on the GURU.Markets platform shows quotes at 0.01. Exoskeleton assembly capacities are operating steadily with targeted updates to calibration systems. Revenue is driven by the sale of high-margin ReWalk devices for mobility restoration in paralysis cases. However, the high cost of the devices and challenges with insurance reimbursements are constraining the pace of business expansion.

ReWalk Robotics (LFWD) - Company Book Value from 02/21/2024 to 10/27/2026

Financial and market metric breakdowns for Lifeward (LFWD)

- price and consensus price forecast:
Stock Quotes Lifeward Ltd.|LFWD - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization ReWalk Robotics Ltd.|LFWD - Total Company Value
- book capitalization data:
Net Assets per Share Lifeward|LFWD - Company Book Value|Market Capitalization to Net Assets rewalk.com|LFWD - Company Total Assets
- debt and liquidity data:
Debt to Capital ReWalk Robotics Ltd.|LFWD - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio ReWalk Robotics|LFWD - Company Aggregate Debts|Debts to Net Assets ReWalk Robotics Ltd.
Summary company analytics:LFWD - Lifeward Ltd.
Mass-produced product of ReWalk Robotics Ltd

When selecting issuers, fundamental analysis requires comparing market value with tangible assets to eliminate speculative overheating. The book value of ReWalk Robotics Ltd. (LFWD) net assets, amounting to 0.01, reflects the remaining equity minus all liabilities, confirming the material foundation of ReWalk Robotics Ltd. (LFWD) innovations in robotic rehabilitation and allowing for an assessment of the business's true scalability regardless of market hype.

Competitor analysis for ReWalk Robotics Ltd.

BSX - Company Net Assets|Book Capitalization Edwards Lifesciences|RMD (resmed.com) - Accounting Capitalization|PODD: Company Book Value|Book Valuation of Business ZBH|COO - Company Book Value|Net Asset Value Align Corp (ALGN)|GMED: Book Capitalization|Total Stockholders' Equity TransMedics Organ Care System TMDX|ATEC: Book Capitalization|AORT - Company Net Assets|DJO Global - Book Capitalization|Integra LifeSciences Inc. (IART) - Book Valuation of Business|ESTA (Establishment Labs) - Book Capitalization|Book Capitalization BBNX|Company Book Value IRADIMED (IRMD)|Company Book Value Embecta Corp (EMBC)|Book Capitalization TNDM|AXGN - Book Valuation of Business|Company Net Assets SI-BONE, Inc.|OFIX - Net Asset Value|Book Capitalization BVS|OrthoPediatrics (KIDS) - Total Stockholders' Equity|Book Capitalization Treace Medical (TMCI)|Accounting Capitalization Strata Medical (SRTA)|Carlsmed Inc (CARL) - Company Net Assets|Accounting Value of Company RXST (rxsight.com)|ClearPoint Neuro - Company Book Value|Company Net Assets Stereotaxis Inc STXS|STIM (NeuroStar) - Book Capitalization|SGHT - Total Stockholders' Equity|Book Capitalization Orchestra BioMed|Anika Therapeutics, Inc. (ANIK) - Accounting Capitalization|NSPR: Book Capitalization|Book Valuation of Business Jin Medical International Ltd|Book Capitalization VANI (Vivani Medical, Inc.)|Company Net Assets xtantmedical.com (XTNT)|Book Capitalization NMTC (NeuroOne Medical Technologies)|Modular Medical Inc - Book Capitalization|MYO - Company Book Value|Envoy Medical Inc. (COCH) - Company Book Value|Company Net Assets Vivos Therapeutics, Inc VVOS|enVVeno Corp (NVNO) - Accounting Value of Company|Book Capitalization SINT (Sintx Technologies Inc)|Total Stockholders' Equity TNON|AMIX: Company Book Value|Book Value of Business INVO Bioscience IVF|Company Net Assets BBLG (Bone Biologics Corporation)|Book Capitalization Axonics, Inc AXNX|Book Capitalization BIOL (BIOLASE, Inc.)|DYNT: Book Valuation of Business|Company Book Value paragon28.com (FNA)|INVO (INVO Bioscience) - Net Asset Value